Search

Press release

SPHINGONY wins Award of Merit at PCHi 2014

Essen, March 11, 2014
  • Skin identical molecule rebalancing the life cycle of the hair

  • Healthy scalp, reduced hair loss


Evonik’s latest Hair & Scalp Care active ingredient SPHINGONY, has won an Award of Merit in the China Personal Care & Cosmetics Innovation Award category for 2014.

Having healthy hair embedded in a healthy scalp is essential to prevent hair loss. SPHINGONY is a naturally occurring, skin-identical sphingolipid which prevents hair loss by addressing scalp health and rebalancing the life cycle of the hair.

The "China Personal Care & Cosmetics Innovation Awards" are co-organized by Ringier Trade Media and magazine HAPPI China as well as by Reed Sinopharm Exhibitions and its trade show PCHi. The purpose of the Awards is to encourage, acknowledge and reward those individuals and companies who have introduced and developed a new idea, methodology, product, or technology for manufacturing production efficiency, cost effectiveness, or user convenience. In addition to these traits, it must also result in energy savings and responsible clean manufacturing in the coatings industry. Winners were announced at the award ceremony at PCHi 2014.

Please find appropriate further information on SPHINGONY on our Personal Care website: www.evonik.com/personal-care

Contact

Janna Hullmann

Vice President Communications Consumer Specialties

Lisa Dierks

Consumer Specialties

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.